Klotho endows hepatoma cells with resistance to anoikis via VEGFR2/PAK1 activation in hepatocellular carcinoma

• Published in: PloS one 2013-03, Vol.8 (3), p.e58413-e58413
• Main Authors: Chen, Lin, Liu, Haiou, Liu, Jing, Zhu, Yu, Xu, Le, He, Hongyong, Zhang, Heng, Wang, Shanshan, Wu, Qian, Liu, Weisi, Liu, Yidong, Pan, Deng, Ren, Shifang, Xu, Jiejie, Gu, Jianxin
• Format: Article
• Language: English
• Subjects: Aging; Allosteric properties; Anoikis; Anoikis - genetics; Antibodies; Apoptosis; Biochemistry; Biology; Blocking antibodies; Cancer; Cancer metastasis; Carcinoma, Hepatocellular - genetics; Carcinoma, Hepatocellular - metabolism; Carcinoma, Hepatocellular - mortality; Carcinoma, Hepatocellular - pathology; Cell Line, Tumor; Cell Proliferation; Cirrhosis; Development and progression; Enzyme Activation; Female; Glucuronidase - genetics; Glucuronidase - metabolism; Hepatocellular carcinoma; Hepatoma; Hospitals; Humans; Inhibitors; Insulin-like growth factors; Kinases; Klotho protein; Liver; Liver cancer; Liver cirrhosis; Liver Neoplasms - genetics; Liver Neoplasms - metabolism; Liver Neoplasms - mortality; Liver Neoplasms - pathology; Male; Medical research; Medicine; Metastases; Metastasis; Middle Aged; Molecular biology; Neoplasm Grading; Neoplasm Staging; Oxidative stress; p21-activated kinase; p21-activated kinase 1; p21-Activated Kinases - metabolism; Patients; Plasmids; RNA Interference; Science; Senescence; Signal Transduction; Signaling; Survival; Tumors; Urology; Vascular Endothelial Growth Factor Receptor-2 - metabolism
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0058413

Klotho was originally characterized as an aging suppressor gene that predisposed Klotho-deficient mice to premature aging-like syndrome. Although Klotho was recently reported to exhibit tumor suppressive properties during various malignant transformations, the functional role and molecular mechanism of Klotho in hepatocarcinogenesis remains poorly understood. In our present study, immunohistochemical Klotho staining levels in a clinical follow-up of 52 hepatoma patients were significantly associated with liver cirrhosis, tumor multiplicity and venous invasion. The overall survival rate of hepatoma patients with high Klotho expression was significantly lower than those patients with low Klotho expression. Moreover, Klotho overexpression increased cellular migration, anchorage-independent growth, and anoikis resistance in hepatoma cells. Klotho overexpression elevated p21-activated kinase 1 (PAK1) expression and shRNA-mediated PAK1 knockdown and kinase activity inhibition with kinase dead mutant PAK1 K299R coexpression or allosteric inhibitor IPA3 treatment reversed anoikis resistance in Klotho-overexpressed hepatoma cells. More importantly, the pivotal significance of upregulated VEGFR2 protein levels mediated by Klotho expression was confirmed by VEGFR2 inhibitor Axitinib and blocking antibody treatment in hepatoma cells. Axitinib treatment sensitized anoikis was reversed by constitutive active mutant PAK1 T423E coexpression in Klotho-overexpressed hepatoma cells. Conversely, knockdown of Klotho reduced VEGFR2/PAK1 dependent anoikis resistance, which could be reversed by PAK1 T423E. These results revealed a novel oncogenic function of Klotho in promoting anoikis resistance via activating VEGFR2/PAK1 signaling, thus facilitating tumor migration and invasion during hepatoma progression, which could provide a putative molecular mechanism for tumor metastasis.